Trials / Completed
CompletedNCT04952389
Acupuncture Therapy for COVID-Related Olfactory Loss
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is looking at the role of acupuncture as a treatment for olfactory dysfunction in patients who tested positive for COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Acupuncture Therapy | Consists of two treatments per week for five weeks |
| DRUG | Budesonide | Twice daily nasal rinses with steroid medication (budesonide) |
| OTHER | Olfactory Training | involves smelling 4 different essential oils (e.g. rose, lemon, clove, and eucalyptus) twice a day for 20 seconds each (after the nasal rinse) |
Timeline
- Start date
- 2021-12-07
- Primary completion
- 2023-04-21
- Completion
- 2023-06-09
- First posted
- 2021-07-07
- Last updated
- 2024-03-12
- Results posted
- 2024-03-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04952389. Inclusion in this directory is not an endorsement.